Regional case wide presentation on Friday. I wish I had answered the questions better…I need learn and calm down when answering questions
Cross sensitivity between carbapenem and penicillin:
A wide range of cross-reactivity between penicillins and carbapenems has been reported in various studies; however, more recent prospective studies have shown the incidence of cross-reactivity between penicillin and carbapenem skin tests to be around 1%. (1)
Concerning cross-reactivity between penicillins and carbapenems, three retrospective clinical studies reported rates of reaction to carbapenems of 9 to 11 percentamong inpatients with a reported penicillin allergy. (1,2,3)
The frequency of carbapenem hypersensitivity was reported as 9.2% versus 3.9% (15 of 163 patients with vs 4 of 103 without reported penicillin allergy, p=0.164). (5)
References:
(1) Frumin J, Gallagher JC.Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?Ann Pharmacother. 2009 Feb;43(2):304-15. Epub 2009 Feb 3.
2. Prescott WA Jr, DePestel DD, Ellis JJ, et al. Incidence of carbapenem-associated allergic reactions among patients with versus patients without a reported penicillin allergy. Clin Infect Dis 2004;38:1102-1107. [Medline][UBC’s eLink
3. McConnell SA, Penzak SR, Warmack TS, Anaissie EJ, Gubbins PO. Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy. Clin Infect Dis 2000;31:1512-1514. [Medline][UBC’s eLink]
4.Sodhi M, Axtell SS, Callahan J, Shekar R. Is it safe to use carbapenems in patients with a history of allergy to penicillin? J Antimicrob Chemother 2004;54:1155-1157. [Free Full Text]
5. Medscape Pharmacists.Carbapenem Hypersensitivity in Patients with Penicillin Allergy: Clinical Studies. http://www.medscape.com/viewarticle/552160_3
FMI:
- ampicillin= amoxicilin
- pen po F: 60%; 600 mg ~ 1 million units; po only used for strep throat
- no antiviral for adenovirus ( well, there is, but it is very toxic)
- pip/tazo ~time dependent–> therefore, adjust dose
- concentration dependent–> adjust interval
Drug Counselling:
LINEZOLID
- indication: VRE, noscomial infx, skin infection, pneumonia
- ADE: rash ( 0.4-7 %), GI ( diarrhea 2.8-11%, N/V), neurological ( headache 0.5-11.3%) , increase bp, myoclonus, tremor, twitching, fever, sertoneri s/s ( increase HR, sweating, dilated pupil); endocrine: lactic acidosis; hematologic: myelosuppression; neurological: periperhal neuropathy, seizure; ophthalmic: disorder of optic nerve
- MOA: inhibit bacterial ribosomal translation
- A: not affected by food
CHLORAMPHENICOL
- inidcation: menignitis, CF, h influ infection, salmonella
- ADE: neuro(confusion, h/a, neurtoxicity); ophthalmic(burning sensation in eye); psychiatric ( delirium, depression); CV ( gray syndrome in new born ); hematologic ( asplastic anemia–> bone marrow doesn’t prodduce sufficient red cell to replenish stores)
- MOA: bacterostatic, bactericidal in high concentration, bind ribosome–> affect cell membrane
- Monitor: fever, CBC with differentials q 2 days
NITAZOXANIDE
- indication: c. diff ( off label), cryptoporidosis, giardiasis
- ADE: GI ( abd pain, diarrhea, n/v); neurological ( H/A)
- MOA: antiprotozoal activity–> interfere with pyruvate ferredoxin oxitreductase ( PFOR) enzyme dependent electron transfer –> needed for anaerboic energy metab
- A: take with food
- Monitor: improvement in diarrhea
COLISTIN
- indication: GNB, pseudomonas, enterobacter aerogenes, e coli, klebsiella
- ADE: neurolgoical ( dizziness, tingling senstation, paresthesia ( tingling, numbiness, pricking of skin); renal ( nephrotoxicity), resp ( acute resp failure or resp tract paralysis)
- MOA: penetrate and disrupt cell membrane
- Monitor : culture and sensitivity; CVC, s/s improvement, temp, renal function, S/S neuromuscular blockade
Meningitis Didactics
- N meningitis passed by hugging, kissing and other close contact ( ie. college dorms are high risk of sites due to close quarters)
- dexamethasone may decrease risk of hearing loss in children
- septra and FQ are alternatives if patients are allergic to beta lactams
- dexamethasone has shown some benefit only in subgroup analysis for strep pneumo ( pro: decrease neurolgoical deficit; con: decrease inflammation leads to decrease abx penetration)
- prophlaxis only for H influ and meningitis
- acquired: contiguous, hematogenous, trauma
- neonate: e coli, listeria, klebsiella, group C strep, lactobacillus (vaginal flora)
- EVD if increase intracranial pressure ( increase infection, drain, hardward increases risk of infection)
- 1/4 pt die despit tx
- use + vanco if increase ceftriaxone resistance ( IVDU)
- Japanese encephalitis (Japanese: 日本脳炎, Nihon-nōen)—previously known as Japanese B encephalitis to distinguish it from von Economo‘s A encephalitis—is a disease caused by the mosquito-borne Japanese encephalitis virus.
- s/s of meningitis: fever, seizure, headache, mental status alteration, photophobia, looking at eye–> see papuillo edema ~ increased pressure, neck stiffness, hear loss, kernig sign ( lower extremities~ K is after B), brudzinski sign ( Neck)
- kids show non-specific features–> fever, irritability, crying, decrease eating
- WBC : neutrophil ( bacteria), lymphocyte ( viral), monocyte ( listeria monocytogenes), esoinphil ( allergy)
- RBC : WBC 1000:1
- viral = no increase in protein
- inflammation can affect glucose transport mechanism
- serum glucose should be checked ( CSF should be 50% of serum normally)
Vancomycin Tapering
Some authorities believe that patients suffering from repeated recurrences should be treated using a regimen consisting of the intermittent administration of metronidazole (or vancomycin)over a period of weeks or even months and followed by their gradual tapering,or by prophylaxis with low dosesof these antibiotics given daily or on alternating days or weeks,or by use of cholestyramine or other anion binding medications along with specific antibiotics,especially at the end of therapy
Sanford: week 1- qid, week 2- bid, week 3- q24h, week 4-qod; week 5-6 q3d
Vancomycin taper:
Week 1: 10 mg/kg/dose (up to 125 mg) PO Q6 hours
Week 2: 10 mg/kg/dose (up to 125 mg) PO Q12 hours
Week 3: 10 mg/kg/dose (up to 125 mg) PO QD
Week 4: 10 mg/kg/dose (up to 125 mg) PO QOD
Week 5 and 6: 10 mg/kg/dose (up to 125 mg) PO Q3 days
OR Vancomycin pulse therapy:
10 – 40 mg/kg/dose (up to 125 – 500 mg) PO Q 2-3 days for 3 weeks